← Leaderboards
Arash Naeim
University Of California Los Angeles
$2,550,900
Attributed
$2,709,574
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,665,719 · 3
AHRQ$1,479,283 · 1
By mechanism
UL1$39,435,428 · 1
R01$1,479,283 · 1
K23$635,850 · 1
P01$594,441 · 1
Top collaborators
- Arleen F Brown6 shared
- Steven M. Dubinett3 shared
- Mitchell David Wong3 shared
- Laura J Van'T Veer1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Mary J Rotheram-Borus$67,342,409
- Steven Shoptaw$45,062,464
- Marguerita A Lightfoot$39,865,564
- Judith S. Currier$525,401,794
- Judith Cheryl Gasson$28,230,504
Others in their field
Top investigators on “Infrastructure”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$400,978,315
- David Heimbrook · Leidos Biomedical Research, Inc.$393,092,965
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
InfrastructureInnovationResearch PersonnelMedicineHeart DiseasesMedical CenterLos AngelesPersonsHealth OccupationsInstitutionClinical SciencesCommunitiesInformaticsCollaborationsCessation Of LifeMissionMultidisciplinaryCountyDisabilityDiabetes MellitusHealth DisparityPrematureCaliforniaPrograms
Grant awards (16)
UCLA Clinical and Translational Science Institute$9,718,232
UL1 · FY2025 · TR
Core D: Patient Centered Outcomes and Risk Communication$317,348
P01 · FY2025 · CA · contact PI
UCLA Clinical and Translational Science Institute$225,068
UL1 · FY2025 · TR
UCLA Clinical and Translational Science Institute$9,718,232
UL1 · FY2024 · TR
Core D: Patient Centered Outcomes and Risk Communication$277,093
P01 · FY2024 · CA · contact PI
UCLA Clinical and Translational Science Institute$225,068
UL1 · FY2024 · TR
UCLA Clinical and Translational Science Institute$9,733,673
UL1 · FY2023 · TR
UCLA Clinical and Translational Science Institute$9,815,155
UL1 · FY2022 · TR
Sensing in At Risk Populations (SARP): Monitoring performance status, activities of daily living, and independence to promote safe outcomes for elderly patients in rehab, the home and long-term care$492,055
R01 · FY2017 · HS · contact PI
Sensing in At Risk Populations (SARP): Monitoring performance status, activities of daily living, and independence to promote safe outcomes for elderly patients in rehab, the home and long-term care$487,241
R01 · FY2016 · HS · contact PI
Sensing in At Risk Populations (SARP): Monitoring performance status, activities of daily living, and independence to promote safe outcomes for elderly patients in rehab, the home and long-term care$499,987
R01 · FY2015 · HS · contact PI
Treatment of Older Patients with Early Breast Cancer$127,170
K23 · FY2007 · CA · contact PI
Treatment of Older Patients with Early Breast Cancer$127,170
K23 · FY2006 · CA · contact PI
Treatment of Older Patients with Early Breast Cancer$127,170
K23 · FY2005 · CA
Treatment of Older Patients with Early Breast Cancer$127,170
K23 · FY2004 · CA
Treatment of Older Patients with Early Breast Cancer$127,170
K23 · FY2003 · CA